Binding of the transcription factor Slug to the L1CAM promoter is essential for transforming growth factor-β1 (TGF-β)-induced L1CAM expression in human pancreatic ductal adenocarcinoma cells

International Journal of Oncology

Volumn 38, Issue 1, 2011, Pages 257-266

  Geismann, Claudia ^a   Arlt, Alexander ^a   Bauer, Iris ^a   Pfeifer, Marco ^b   Schirmer, Uwe ^b   Altevogt, Peter ^b   Müerköster, Susanne Sebens ^a   Schäfer, Heiner ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Epithelial mesenchymal transition; Gene expression; Transcription factor; Tumorigenesis

Indexed keywords

MEMBRANE PROTEIN; PROTEIN L1CAM; RNA POLYMERASE II; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; E BOX ELEMENT; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE MUTATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PANCREAS DUCT; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; HUMANS; NEURAL CELL ADHESION MOLECULE L1; PANCREATIC NEOPLASMS; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 78650814387     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo-00000846     Document Type: Article

References (41)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J and Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 57: 43-66, 2007.
2. Polyak K and Weinberg RA: Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273, 2009.
3. Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558, 2005.
4. Kabashima A, Higuchi H, Takaishi H, et al: Side population of pancreatic cancer cells predominates in TGF-beta-mediated epithelial to mesenchymal transition and invasion. Int J Cancer 124: 2771-2779, 2009.
5. Moustakas A and Heldin CH: Signaling networks guiding epithelial-mesenchymal transitions during embryogenesis and cancer progression. Cancer Sci 98: 1512-1520, 2007.
6. Cui W, Fowlis DJ, Bryson S, et al: TGFbeta1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice. Cell 86: 531-542, 1996.
7. Ellenrieder V, Hendler SF, Boeck W, et al: Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation. Cancer Res 61: 4222-4228, 2001.
8. Hemavathy K, Ashraf SI and Ip YT: Snail/slug family of repressors: slowly going into the fast lane of development and cancer. Gene 257: 1-12, 2000.
9. Alves CC, Carneiro F, Hoefler H and Becker KF: Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers. Front Biosci 14: 3035-3050, 2009.
10. Batlle E, Sancho E, Franci C, et al: The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2: 84-89, 2000.
11. Cano A, Perez-Moreno MA, Rodrigo I, et al: The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression. Nat Cell Biol 2: 76-83, 2000.
12. Zavadil J and Bottinger EP: TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24: 5764-5774, 2005.
13. De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F and Berx G: The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program. Cancer Res 65: 6237-6244, 2005.
14. Barrallo-Gimeno A and Nieto MA: The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development 132: 3151-3161, 2005. (Pubitemid 41167144)
15. Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ and Hotz HG: Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res 13: 4769-4776, 2007.
16. Geismann C, Morscheck M, Koch D, et al: Up-regulation of L1CAM in pancreatic duct cells is transforming growth factor beta1- and slug-dependent: role in malignant transformation of pancreatic cancer. Cancer Res 69: 4517-4526, 2009.
17. Moos M, Tacke R, Scherer H, Teplow D, Fruh K and Schachner M: Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature 334: 701-703, 1988.
18. Maness PF and Schachner M: Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci 10: 19-26, 2007.
19. Weidle UH, Eggle D and Klostermann S: L1-CAM as a target for treatment of cancer with monoclonal antibodies. Anticancer Res 29: 4919-4931, 2009.
20. Fogel M, Mechtersheimer S, Huszar M, et al: L1 adhesion molecule (CD 171) in development and progression of human malignant melanoma. Cancer Lett 189: 237-247, 2003.
21. Gavert N, Conacci-Sorrell M, Gast D, et al: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol 168: 633-642, 2005.
22. Sebens Muerkoster S, Werbing V, Sipos B, et al: Drug-induced expression of the cellular adhesion molecule L1CAM confers anti-apoptotic protection and chemoresistance in pancreatic ductal adenocarcinoma cells. Oncogene 26: 2759-2768, 2007.
23. Boo YJ, Park JM, Kim J, et al: L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer. Ann Surg Oncol 14: 1703-1711, 2007. (Pubitemid 46790990)
24. Fogel M, Gutwein P, Mechtersheimer S, et al: L1 expression as a predictor of progression and survival in patients with uterine and ovarian carcinomas. Lancet 362: 869-875, 2003.
25. Kaifi JT, Reichelt U, Quaas A, et al: L1 is associated with micrometastatic spread and poor outcome in colorectal cancer. Mod Pathol 20: 1183-1190, 2007.
26. Rawnaq T, Kleinhans H, Uto M, et al: Subset of esophageal adenocarcinoma expresses adhesion molecule l1 in contrast to squamous cell carcinoma. Anticancer Res 29: 1195-1199, 2009.
27. Furukawa T, Duguid WP, Rosenberg L, Viallet J, Galloway DA and Tsao MS: Long-term culture and immortalization of epithelial cells from normal adult human pancreatic ducts transfected by the E6E7 gene of human papilloma virus 16. Am J Pathol 148: 1763-1770, 1996.
28. Muerkoster SS, Werbing V, Koch D, et al: Role of myofibroblasts in innate chemoresistance of pancreatic carcinoma-epigenetic downregulation of caspases. Int J Cancer 123: 1751-1760, 2008.
29. Sebens Muerkoster S, Kotteritzsch J, Geismann C, et al: alpha5-integrin is crucial for L1CAM-mediated chemoresistance in pancreatic adenocarcinoma. Int J Oncol 34: 243-253, 2009.
30. Kallunki P, Edelman GM and Jones FS: Tissue-specific expression of the L1 cell adhesion molecule is modulated by the neural restrictive silencer element. J Cell Biol 138: 1343-1354, 1997.
31. Sipos B, Moser S, Kalthoff H, Torok V, Lohr M and Kloppel G: A comprehensive characterization of pancreatic ductal carcinoma cell lines: towards the establishment of an in vitro research platform. Virchows Arch 442: 444-452, 2003. (Pubitemid 36718311)
32. Kimura K, Wakamatsu A, Suzuki Y, et al: Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes. Genome Res 16: 55-65, 2006.
33. Jethwa P, Naqvi M, Hardy RG, et al: Overexpression of Slug is associated with malignant progression of esophageal adenocarcinoma. World J Gastroenterol 14: 1044-1052, 2008.
34. Medici D, Hay ED and Goodenough DA: Cooperation between snail and LEF-1 transcription factors is essential for TGF-beta1-induced epithelial-mesenchymal transition. Mol Biol Cell 17: 1871-1879, 2006.
35. Peinado H, Quintanilla M and Cano A: Transforming growth factor beta-1 induces snail transcription factor in epithelial cell lines: mechanisms for epithelial mesenchymal transitions. J Biol Chem 278: 21113-21123, 2003.
36. Chen WB, Lenschow W, Tiede K, Fischer JW, Kalthoff H and Ungefroren H: Smad4/DPC4-dependent regulation of biglycan gene expression by transforming growth factor-beta in pancreatic tumor cells. J Biol Chem 277: 36118-36128, 2002.
37. Layton T, Stalens C, Gunderson F, Goodison S and Silletti S: Syk tyrosine kinase acts as a pancreatic adenocarcinoma tumor suppressor by regulating cellular growth and invasion. Am J Pathol 175: 2625-2636, 2009.
38. Huszar M, Pfeifer M, Schirmer U, et al: Up-regulation of L1CAM is linked to loss of hormone receptors and E-cadherin in aggressive subtypes of endometrial carcinomas. J Pathol (In press).
39. Kurrey NK, Jalgaonkar SP, Joglekar AV, et al: Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells. Stem Cells 27: 2059-2068, 2009.
40. Shtutman M, Levina E, Ohouo P, Baig M and Roninson IB: Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res 66: 11370-11380, 2006.
41. Bergmann F, Wandschneider F, Sipos B, et al: Elevated L1CAM expression in precursor lesions and primary and metastastic tissues of pancreatic ductal adenocarinoma. Oncol Rep 24: 909-915, 2010.